Creating stable antibody replacements on demand
Technology to Create Spiegel ERAbodies on Demand: Biostable Universal Antibody Replacements
This study is exploring a new kind of antibody replacement called Spiegel ERAbodies, which can be made quickly and easily to help scientists better understand diseases and improve treatments, making the process faster and more affordable.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Foundation for Applied Molecular Evolutn NIH-funded |
| Lab location | 1 site (Alachua, United States) |
| Project ID | NIH-10707168 on NIH RePORTER |
What this research studies
This research focuses on developing a new type of antibody replacement called Spiegel ERAbodies, which can be created on demand for use in various biomedical applications. The approach utilizes an innovative platform that incorporates an expanded RNA alphabet, allowing for greater binding potential and stability compared to traditional antibodies. By enhancing the structural diversity and folding capabilities of these replacements, the researchers aim to provide a more reliable and efficient tool for scientists studying biological processes. This could significantly reduce the time and cost associated with producing antibodies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals involved in biomedical research or clinical diagnostics who require stable and effective binding agents for their studies.
Not a fit: Patients who are not engaged in research or clinical diagnostics may not benefit directly from this technology.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and reliable tools for diagnosing and treating diseases.
How similar studies have performed: While the concept of antibody replacements has been explored, the specific approach using an expanded RNA alphabet is novel and has not been extensively tested.
Where this research is happening
Alachua, United States
- Foundation for Applied Molecular Evolutn — Alachua, United States (Active)
Researchers
- Principal investigator: Biondi, Elisa — Foundation for Applied Molecular Evolutn
- Study coordinator: Biondi, Elisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.